Similarly, a decrease in the C‐peptide response was detected at the high dose of infused insulin, and a tendency during the low dose compared to baseline, in the individuals with type 2 diabetes, whereas a decrease occurred during both clamp stages in the healthy controls before MR blockade. This evidence concerns the gene INS and type 2 diabetes mellitus.